Cargando…

A comparative pharmacokinetic study of a novel sustained release danofloxacin formulation and the conventional product in rabbits

Sustained release drug formulations are frequently developed to reduce dosage frequency and to improve outcomes of drug therapy. This study evaluates the pharmacokinetic (PK) parameters of a novel injectable danofloxacin (DANO) formulation in comparison with a conventional product in an animal model...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rassouli, Ali, Kiani, Katayoun, Hosseinzadeh Ardakani, Yalda, Akbari Javar, Hamid, Khanamani Falahatipour, Sakineh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Urmia University Press 2021
Materias:	Short Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8328252/ https://www.ncbi.nlm.nih.gov/pubmed/34345395 http://dx.doi.org/10.30466/vrf.2019.105313.2504

Ejemplares similares

In Vivo Pharmacokinetic/Pharmacodynamic Profiles of Danofloxacin in Rabbits Infected With Salmonella typhimurium After Oral Administration
por: Xiao, Xia, et al.
Publicado: (2018)

Effects of danofloxacin dosing regimen on gastrointestinal pharmacokinetics and fecal microbiome in steers
por: Halleran, J. L., et al.
Publicado: (2021)

Pharmacokinetics of Danofloxacin in Gushi Chickens after Single Oral and Intravenous Administration
por: Chen, Jun-Cheng, et al.
Publicado: (2023)

An in vivo pharmacokinetic study of metformin microparticles as an oral sustained release formulation in rabbits
por: Bouriche, Sihem, et al.
Publicado: (2021)

Formulation and In Vitro, In Vivo Evaluation of Effervescent Floating Sustained-Release Imatinib Mesylate Tablet
por: Kadivar, Ali, et al.
Publicado: (2015)

Impact of bovine respiratory disease on the pharmacokinetics of danofloxacin and tulathromycin in different ages of calves
por: Mzyk, Danielle A., et al.
Publicado: (2019)

The influence of immune stress induced by Escherichia coli lipopolysaccharide on the pharmacokinetics of danofloxacin in broilers
por: Wang, Han, et al.
Publicado: (2021)

Pharmacokinetics of intravenous and intramuscular danofloxacin in red-eared slider turtles (Trachemys scripta elegans)
por: CORUM, Orhan, et al.
Publicado: (2019)

Comparisons of plasma and fecal pharmacokinetics of danofloxacin and enrofloxacin in healthy and Mannheimia haemolytica infected calves
por: Beyi, Ashenafi Feyisa, et al.
Publicado: (2022)

Pharmacokinetic/Pharmacodynamic Integration to Evaluate the Changes in Susceptibility of Actinobacillus pleuropneumoniae After Repeated Administration of Danofloxacin
por: Zhang, Longfei, et al.
Publicado: (2018)

Pharmacokinetics and pharmacodynamics integration of danofloxacin against Eschrichia coli in piglet ileum ultrafiltration probe model
por: Yang, Yuqi, et al.
Publicado: (2021)

Pharmacokinetic Behavior and Pharmacokinetic/Pharmacodynamic Integration of Danofloxacin Following Single or Co-Administration with Meloxicam in Healthy Lambs and Lambs with Respiratory Infections
por: Ural, Mehmet Nihat, et al.
Publicado: (2021)

Gender Dependency in Streoselective Pharmacokinetics of Tramadol and Its Phase I Metabolites in Relation to CYP2D6 Phenotype in Iranian Population
por: Hosseinzadeh Ardakani, Yalda, et al.
Publicado: (2018)

Spectrofluorimetric determination of cefixime using terbium-danofloxacin probe
por: Manzoori, Jamshid L., et al.
Publicado: (2014)

Susceptibility breakpoint for Danofloxacin against swine Escherichia coli
por: Yang, Yuqi, et al.
Publicado: (2019)

Population Pharmacokinetics of Danofloxacin in Yellow River Carp (Cyprinus carpio haematopterus) After One Single Oral Dose
por: Song, Zhe-Wen, et al.
Publicado: (2022)

Exploration of Clinical Breakpoint of Danofloxacin for Glaesserella parasuis in Plasma and in PELF
por: Xu, Zihui, et al.
Publicado: (2021)

Pharmacokinetic-Pharmacodynamic Model of Newly Developed Dexibuprofen Sustained Release Formulations
por: Muralidharan, Selvadurai
Publicado: (2012)

Spectrofluorimetric Determination of Human Serum Albumin Using Terbium-Danofloxacin Probe
por: Ramezani, Amir M., et al.
Publicado: (2012)

Flaxseed-enriched diets change milk concentration of the antimicrobial danofloxacin in sheep
por: Otero, Jon Andoni, et al.
Publicado: (2018)

Preparation of an Antidanofloxacin Monoclonal Antibody and Development of Immunoassays for Detecting Danofloxacin in Meat
por: Yuan, Meifang, et al.
Publicado: (2020)

Danofloxacin Treatment Alters the Diversity and Resistome Profile of Gut Microbiota in Calves
por: Beyi, Ashenafi Feyisa, et al.
Publicado: (2021)

Effect of Danofloxacin Treatment on the Development of Fluoroquinolone Resistance in Campylobacter jejuni in Calves
por: Goulart, Debora Brito, et al.
Publicado: (2022)

Selection of 12‐Hour Sustained‐Release Acetaminophen (Paracetamol) Formulation Through Comparison of Pharmacokinetic Profiles of 4 Sustained‐Release Prototype Formulations and Standard Acetaminophen Formulation: An Open‐Label, Randomized, Proof‐of‐Principle Pharmacokinetic Study
por: Yue, Yong, et al.
Publicado: (2017)

Patient Satisfaction with Community Pharmacies in Tehran, Iran; Part I
por: SHOKRI, Narges, et al.
Publicado: (2016)

Pharmacokinetics of Ambroxol Sustained Release (Mucosolvan(®) Retard) Compared with Other Formulations in Healthy Volunteers
por: Ollier, Celine, et al.
Publicado: (2020)

Sustained Release of an Anti-Glaucoma Drug: Demonstration of Efficacy of a Liposomal Formulation in the Rabbit Eye
por: Natarajan, Jayaganesh V., et al.
Publicado: (2011)

The in vitro activity of danofloxacin plus ceftiofur combination: implications for antimicrobial efficacy and resistance prevention
por: Cengiz, Murat, et al.
Publicado: (2022)

Evaluation of the mutant selection window of danofloxacin against Actinobacillus pleuropneumoniae in an in vitro dynamic model
por: Zhang, Longfei, et al.
Publicado: (2023)

A review of conventional and sustained-release formulations of oral natural micronized progesterone in obstetric indications
por: Wagh, Girija Narendrakumar, et al.
Publicado: (2021)

The PK–PD Relationship and Resistance Development of Danofloxacin against Mycoplasma gallisepticum in An In Vivo Infection Model
por: Zhang, Nan, et al.
Publicado: (2017)

Analysis of the mutant selection window and killing of Mycoplasma hyopneumoniae for doxycycline, tylosin, danofloxacin, tiamulin, and valnemulin
por: Huang, Zilong, et al.
Publicado: (2020)

Pharmacokinetics of immediate and sustained-release formulations of paroxetine: Population pharmacokinetic approach to guide paroxetine personalized therapy in chinese psychotic patients
por: Li, Xiao-lin, et al.
Publicado: (2022)

Proniosomal Telmisartan Tablets: Formulation, in vitro Evaluation and in vivo Comparative Pharmacokinetic Study in Rabbits
por: Teaima, Mahmoud Hasan, et al.
Publicado: (2020)

Preliminary Investigation into a Novel Sustained-Release Formulation of Meloxicam in Sheep (Ovis aries)—Pharmacokinetic Profile
por: Plummer, Christine, et al.
Publicado: (2021)

Determination of the Mutant Selection Window and Evaluation of the Killing of Mycoplasma gallisepticum by Danofloxacin, Doxycycline, Tilmicosin, Tylvalosin and Valnemulin
por: Zhang, Nan, et al.
Publicado: (2017)

Toxic effects of methylmercury, arsanilic acid and danofloxacin on the differentiation of mouse embryonic stem cells into neural cells
por: Kang, Seok-Jin, et al.
Publicado: (2014)

Relationship between danofloxacin PK/PD parameters and emergence and mechanism of resistance of Mycoplasma gallisepticum in In Vitro model
por: Zhang, Nan, et al.
Publicado: (2018)

Comparison of PK/PD Targets and Cutoff Values for Danofloxacin Against Pasteurella multocida and Haemophilus parasuis in Piglets
por: Zhou, Yu-Feng, et al.
Publicado: (2022)

Rational Use of Danofloxacin for Treatment of Mycoplasma gallisepticum in Chickens Based on the Clinical Breakpoint and Lung Microbiota Shift
por: Wang, Shuge, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_os5al6sit9bgkb1chq77l175g5